a 215 oxycodone 30 mg actavis

a 215 oxycodone 30 mg actavis (oxycodone hydrochloride tablets USP) is an opioid analgesic. Oxycodone hydrochloride is a white, odorless crystalline powder derived from the opium
alkaloid, thebaine. Oxycodone hydrochloride dissolves in water (1 g in 6 to 7 mL) and is
considered slightly soluble in alcohol (octanol water partition coefficient is 0.7).

A 215 (Oxycodone Hydrochloride 30 mg)

Pill with imprint A 215 is Blue, Round and has been identified as Oxycodone Hydrochloride 30 mg. It is supplied by Actavis.

Oxycodone is used in the treatment of chronic pain; pain and belongs to the drug class narcotic analgesics. FDA has not classified the drug for risk during pregnancy. Oxycodone 30 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Pharmacology:

The analgesic ingredient, oxycodone, is a semi-synthetic narcotic with multiple actions
qualitatively similar to those of morphine; the most prominent of these involves the central
nervous system and organs composed of smooth muscle.

INDICATIONS AND USAGE

a 215 oxycodone 30 mg tablets are an immediate-release oral formulation of a 215 oxycodone 30 mg hydrochloride indicated for the management of moderate to severe pain where the use of an
opioid analgesic is appropriate.

Drug Interactions:

Oxycodone is metabolized in part to oxymorphone via the cytochrome p450 isoenzyme
CYP2D6. While this pathway may be blocked by a variety of drugs (e.g., certain
cardiovascular drugs and antidepressants), such blockade has not yet been shown to be of
clinical significance with this agent. However, clinicians should be aware of this possible
interaction.